#1 Clinical Trials Search in Europe

Tamoxifen Citrate

Tamoxifen Citrate, a widely used medication in cancer treatment, is being studied in various clinical trials to explore its potential benefits in different medical conditions. This article summarizes key findings from recent clinical trials investigating the use of Tamoxifen Citrate in treating bladder tumors, oesophageal cancer, breast cancer, and other conditions. We’ll explore the drug’s mechanisms, potential benefits, and ongoing research efforts to expand its therapeutic applications.

Table of Contents

What is Tamoxifen Citrate?

Tamoxifen Citrate is a medication widely used in the treatment of certain types of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamoxifen Citrate is also known by several other names, including Nolvadex, Soltamox, and simply Tamoxifen[1]. This medication has been in use for over 30 years and has helped millions of women in their fight against breast cancer[1].

Uses of Tamoxifen Citrate

Tamoxifen Citrate is primarily used in the treatment and prevention of breast cancer. Its main applications include:

  • Treatment of Breast Cancer: It is used to treat various stages of breast cancer, including early-stage, advanced, and metastatic (cancer that has spread to other parts of the body) breast cancer[2].
  • Prevention of Breast Cancer Recurrence: In women who have already been treated for breast cancer, Tamoxifen can help prevent the cancer from coming back[3].
  • Breast Cancer Prevention: In some cases, Tamoxifen may be prescribed to women at high risk of developing breast cancer to reduce their chances of getting the disease[1].
  • Treatment of Ductal Carcinoma In Situ (DCIS): This is a non-invasive type of breast cancer[4].

Interestingly, Tamoxifen is also being studied for its potential use in other conditions. For example, it’s being investigated for the treatment of bladder cancer[5] and esophageal cancer[6]. Additionally, it has been used in fertility treatments to induce ovulation in women with polycystic ovary syndrome (PCOS)[7].

How Tamoxifen Citrate Works

Tamoxifen Citrate works by blocking the effects of estrogen in breast tissue. Many breast cancers are stimulated to grow by estrogen, a hormone naturally produced in the body. These types of breast cancers are called estrogen receptor-positive (ER-positive) breast cancers[3].

By blocking estrogen’s effects, Tamoxifen can:

  • Slow or stop the growth of existing breast cancer cells
  • Prevent cancer cells from dividing and multiplying
  • Reduce the risk of cancer developing in unaffected breast tissue

It’s important to note that Tamoxifen is most effective in treating hormone receptor-positive breast cancers. These are cancers whose cells have receptors for estrogen (ER-positive) and/or progesterone (PR-positive)[4].

How Tamoxifen Citrate is Administered

Tamoxifen Citrate is typically taken orally in the form of tablets. The dosage and duration of treatment can vary depending on the specific condition being treated and individual patient factors. Some common regimens include:

  • For breast cancer treatment: 20mg daily for 5 years or longer[2]
  • For breast cancer prevention in high-risk women: 20mg daily for 5 years[1]
  • For fertility treatment in PCOS: 10-20mg daily for 5 days, starting on the 3rd day of the menstrual cycle[7]

It’s crucial to take Tamoxifen exactly as prescribed by your doctor. The medication is typically taken for several years to get the full benefit.

Potential Side Effects

Like all medications, Tamoxifen can cause side effects. Common side effects may include:

  • Hot flashes
  • Nausea
  • Fatigue
  • Mood swings
  • Vaginal discharge or dryness
  • Irregular menstrual periods

More serious but less common side effects can include:

  • Blood clots
  • Stroke
  • Cataracts
  • Endometrial cancer (cancer of the uterine lining)

It’s important to discuss any side effects with your healthcare provider[7].

Ongoing Research

Researchers continue to study Tamoxifen to understand its full potential and optimize its use. Some areas of ongoing research include:

  • Duration of Treatment: Studies are investigating whether shorter durations of Tamoxifen treatment (e.g., 2 years instead of 5) might be sufficient for some low-risk breast cancers[4].
  • Combination Therapies: Researchers are exploring how Tamoxifen works in combination with other drugs to improve its effectiveness[8].
  • Use in Other Cancers: As mentioned earlier, Tamoxifen is being studied for its potential in treating other types of cancer, such as bladder and esophageal cancer[5][6].
  • Personalized Medicine: Studies are looking at how genetic factors might influence a person’s response to Tamoxifen, with the goal of tailoring treatment to individual patients[9].

Tamoxifen Citrate has been a cornerstone in breast cancer treatment for decades, and ongoing research continues to refine and expand its use. If you have any questions about Tamoxifen or its use in your treatment, don’t hesitate to discuss them with your healthcare provider.

Condition Study Type Dosage Key Findings/Objectives
Bladder Tumors Phase II Trial 20mg daily for 12 weeks Evaluating efficacy for low/intermediate-risk bladder tumors
Oesophageal Cancer Pilot Study Daily for 4 weeks Assessing effect on cancer cell growth
Metastatic Breast Cancer Phase II Trial Daily, duration not specified Correlating CYP2D6 activity with progression-free survival
Early Breast Cancer Phase II Trial Daily for 2 years Testing shortened duration of therapy in low-risk patients
Liver Cancer Phase III Trial High-dose, twice daily for one year Comparing with placebo for inoperable hepatocellular carcinoma
Bipolar Disorder (Acute Mania) Randomized Controlled Trial 80mg/day for 3 weeks Investigating anti-manic properties
Breast Cancer Prevention Phase II Trial Daily for 3 months Studying biomarkers in high-risk women

FAQ

  • What is Tamoxifen Citrate and how does it work? Tamoxifen Citrate is a medication that belongs to a class of drugs called selective estrogen receptor modulators (SERMs). It works by blocking the effects of estrogen in certain tissues, including breast tissue. This action can help prevent the growth of some types of breast cancer cells that rely on estrogen to grow.
  • In which conditions is Tamoxifen Citrate being studied? According to the clinical trials data, Tamoxifen Citrate is being studied in various conditions including bladder tumors, oesophageal cancer, breast cancer, bipolar disorder, and as a preventive measure for women at high risk of developing breast cancer.
  • What are the potential benefits of Tamoxifen Citrate in bladder cancer? A clinical trial is evaluating the efficacy of Tamoxifen Citrate for treating low/intermediate-risk bladder tumors. The study aims to assess the clinical response of marker lesions to Tamoxifen treatment, which could potentially offer a new treatment option for certain bladder cancer patients.
  • How is Tamoxifen Citrate being used in breast cancer prevention? Tamoxifen Citrate is being studied as a preventive measure for women at increased risk of developing breast cancer. Some trials are investigating its effects on molecular markers of proliferation and apoptosis in breast epithelial tissue, as well as its impact on serum levels of certain growth factors.
  • Are there any non-cancer related conditions where Tamoxifen Citrate is being studied? Yes, interestingly, Tamoxifen Citrate is being studied in the treatment of acute mania in bipolar disorder. A clinical trial is investigating whether Tamoxifen, as a protein kinase C inhibitor, has anti-manic properties.

Ongoing Clinical Trials on Tamoxifen Citrate

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Comparison of Low-Dose Exemestane versus Low-Dose Tamoxifen for Breast Cancer Prevention in Postmenopausal Women at High Risk

    Recruiting

    2 1 1 1
    Investigated drugs:
    Italy Portugal

  • Study of Fertility Preservation Using Tamoxifen, Follitropin Beta, Cetrorelix and Choriogonadotropin Alfa in Women with Breast Cancer Before Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Elacestrant and Triptorelin for Premenopausal Women with Early Luminal Breast Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Early Detection and Treatment of ER Positive HER2 Negative Breast Cancer Using Palbociclib, Fulvestrant, and Drug Combination for Patients with Molecular Relapse

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on Breast Cancer Prevention in High-Risk Women Using Low Dose Tamoxifen and Lifestyle Changes

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of Abemaciclib and Tamoxifen in Women with Metastatic Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy

Glossary

  • Tamoxifen Citrate: A selective estrogen receptor modulator (SERM) used in the treatment and prevention of certain types of breast cancer. It works by blocking the effects of estrogen in breast tissue.
  • Estrogen Receptor (ER): A protein found inside cells that is activated by the hormone estrogen. In some types of breast cancer, activation of ERs promotes cancer cell growth.
  • HER2: Human Epidermal Growth Factor Receptor 2, a protein that promotes the growth of cancer cells. Some breast cancers have higher than normal levels of HER2 and are called HER2-positive.
  • Endoxifen: An active metabolite of Tamoxifen that is believed to be responsible for much of its anti-estrogenic effects in breast tissue.
  • CYP2D6: An enzyme involved in the metabolism of many drugs, including the conversion of Tamoxifen to its active form, Endoxifen.
  • Progression-Free Survival (PFS): The length of time during and after treatment that a patient lives with the disease but it does not get worse.
  • RECIST: Response Evaluation Criteria in Solid Tumors, a set of rules used to measure how well a cancer patient responds to treatment.
  • Ki67: A protein associated with cell proliferation, often used as a marker to determine how fast cancer cells are growing.
  • Protein Kinase C (PKC): An enzyme involved in cell signaling that plays a role in various cellular processes including cell growth and division.
  • Young Mania Rating Scale (YMRS): A rating scale used to evaluate manic symptoms in patients with bipolar disorder.

References

  1. https://clinicaltrials.gov/study/NCT00066690
  2. https://clinicaltrials.gov/study/NCT00002777
  3. https://clinicaltrials.gov/study/NCT00002646
  4. https://clinicaltrials.gov/study/NCT03917082
  5. https://clinicaltrials.gov/study/NCT02197897
  6. https://clinicaltrials.gov/study/NCT02513849
  7. https://clinicaltrials.gov/study/NCT02479256
  8. https://clinicaltrials.gov/study/NCT02322853
  9. https://clinicaltrials.gov/study/NCT01124695